drugset / Trial / NCT02010645
Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS)
NaSingle-groupOpen-labelTreatment
Summary
The goal of this clinical research study is to learn if eltrombopag given in combination with decitabine can help to control advanced MDS. The safety of this study drug combination will also be studied.
Timeline
- Start
- 2014-03
- Primary completion
- 2019-01-02
- Completion
- 2019-01-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Decitabine | Small molecule | 20 mg/m2 | Intravenous |
| Subject | Eltrombopag | Small molecule | 50 mg | Oral |
| Subject | Eltrombopag | Small molecule | 100 mg | Oral |